ES LeBlanc, E O'Connor, EP Whitlock… - Annals of internal …, 2011 - acpjournals.org
Background: Overweight and obesity in adults are common and adversely affect health. Purpose: To summarize effectiveness and harms of primary care–relevant weight-loss …
A Köttgen, E Albrecht, A Teumer, V Vitart, J Krumsiek… - Nature …, 2013 - nature.com
Elevated serum urate concentrations can cause gout, a prevalent and painful inflammatory arthritis. By combining data from> 140,000 individuals of European ancestry within the …
C Seifarth, B Schehler… - Experimental and clinical …, 2013 - thieme-connect.com
The efficacy of metformin for the treatment of obesity has been evaluated in few clinical trials with inconclusive results. Moreover, the effectiveness in a real-life outpatient setting has not …
Z Li, M Maglione, W Tu, W Mojica… - Annals of internal …, 2005 - acpjournals.org
Background: In response to the increase in obesity, pharmacologic treatments for weight loss have become more numerous and more commonly used. Purpose: To assess the …
AM Kanaya, D Herrington, E Vittinghoff… - Annals of internal …, 2003 - acpjournals.org
Background: Randomized trials of postmenopausal hormone therapy have found differing effects on fasting glucose levels. No trial has evaluated the effect of hormone therapy on …
KM McTigue, R Harris, B Hemphill, L Lux… - Annals of internal …, 2003 - acpjournals.org
Background: Obesity poses a considerable and growing health burden. This review examines evidence for screening and treating obesity in adults. Data Sources: MEDLINE …
Metformin, a biguanide, has been available in the US for the treatment of type 2 diabetes mellitus for nearly 8 years. Over this period of time, it has become the most widely prescribed …
NT Shurrab, ESA Arafa - Obesity medicine, 2020 - Elsevier
Managing obesity is a substantial aspect worldwide as well as in diabetic patients. Most oral antidiabetic medications increase body weight. Metformin, the most recommended first-line …